lobbying_activities: 2460533

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2460533	e7adfc09-0a36-4b72-93e6-c1123dd20f30	Q2	JOHNSON MATTHEY INC.	401104441	JOHNSON MATTHEY INC.	2020	second_quarter	BUD	H.R. 1865, Further Consolidated Appropriations Act of 2020, FY2020 appropriations provisions relating to the general funding levels of the EPA, delaying implementation of the 2015 Ozone NAAQS, funding regulatory work for EPA's Cleaner Trucks Initiative, extending alternative-fueled vehicle tax credits, funding DOE fuel cell-related research and development programs, enhancing first generic drug manufacturers' 180-day exclusivity protections, and process improvements and new FDA authority concerning generic drug manufacturers' access to reference samples from branded drug manufacturers. H.R. 478, Coronavirus Aid, Relief, and Economic Security Act, provisions relating to drug manufacturers to submit more information when there is an interruption in supply, including information about active pharmaceutical ingredients, when active pharmaceutical ingredients are the cause of the interruption, and potential provisions relating to the modification of China 301 tariffs.	Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES		30000	0	0	2020-07-01T08:10:50.653000-04:00